New Key Statistics Module, Z-Score and F-Score
HKSE:02126 Key Ratios
Market Cap HK$ M | 563.53 |
Enterprise Value HK$ M | -226.36 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.30 |
Price/Sales | 5.60 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) HK$ M | 95.00 |
EPS (TTM) HK$ | -1.65 |
Beneish M-Score | -3.78 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -6.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.55 |
EV-to-EBITDA | 0.56 |
PEG | -- |
Shares Outstanding M | 414.36 |
Net Margin (%) | -433.57 |
Operating Margin % | -351.89 |
Pre-tax Margin (%) | -433.57 |
Quick Ratio | 3.90 |
Current Ratio | 4.04 |
ROA % (ttm) | -14.92 |
ROE % (ttm) | -18.32 |
ROIC % (ttm) | -21.18 |
Dividend Yield % | -- |
Altman Z-Score | -3.26 |
HKSE:02126 Number of Guru Trades
HKSE:02126 Volume of Guru Trades
Gurus Latest Trades with HKSE:02126
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:02126 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
JW (Cayman) Therapeutics Co Ltd Insider Transactions
No Available Data